Showing 691-700 of 1942 results for "".
My Experience Treating Patients with Visually Induced Trigeminal Dysphoria
https://modernod.com/articles/visually-induced-dysphoria-a-potential-leading-source-of-headaches-eyestrain-and-dry-eye-sensation/my-experience-treating-patients-with-visually-induced-trigeminal-dysphoria/37974/A new technology resolves symptoms initially thought to be dry eye disease.GA Case Compendium: Identification of Geographic Atrophy on Color Fundus Photography
https://modernod.com/resources/geographic-atrophy-case-compendium/ga-case-compendium-identification-of-geographic-atrophy-on-color-fundus-photography/56702/Overcoming Treatment Plateaus in Chronic DME
https://modernod.com/specialty/retina/Overcoming-Treatment-Plateaus-in-Chronic-DME-2506/33190/Learn about a patient with a 9-year history of injections for treatment of retinal disease and the final approach resulting in positive outcomes.Alcon Announces Plans to Acquire Lensar
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-announces-plans-to-acquire-lensar/37077/Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch + Lomb announces results from a phase 4 extension study of dry eye disease drug Miebo. Learn more about your ad choices. Visit megaphone.fm/adchoNorlase Launches First Pattern Scanning LIO
https://modernod.com/podcasts/eyewire-news-the-podcast/norlase-launches-first-pattern-scanning-lio/37069/The world’s first and only pattern scanning laser indirect ophthalmoscope is approved in the US and Europe; the European Commission approves a biosimilar to Eylea; and we review several clinical updates in the development of ophthalmic drugs. Learn more about your ad choices. Visit megaphone.fm/adch93. Thriving, Not Just Surviving: A Mental Health Check-In for New Grads ft. Dr. Meenal Agarwal
https://modernod.com/podcasts/four-eyes/93-thriving-not-just-surviving-a-mental-health-check-in-for-new-grads-ft-dr-meenal-agarwal/37043/In this refreshingly honest episode, we chat with Dr. Meenal Agarwal, an Optometrist and private practice owner, about the mental health challenges that often come with life after optometry school.Geared toward students and new grads, this conversation covers:•What burnout really feels like and whenHarrow Adds Biosimilars to US Portfolio
https://modernod.com/podcasts/eyewire-news-the-podcast/harrow-adds-biosimilars-to-us-portfolio/37094/Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoicesAECOS Presentation Summaries
https://modernod.com/podcasts/eyewire-news-the-podcast/aecos-presentation-summaries/37093/Leading ophthalmologists share summaries of their presentations live from thee AECOS Summer Symposium. Learn more about your ad choices. Visit megaphone.fm/adchoicesB+L Launches New Scleral Lenses Technology
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-launches-new-scleral-lenses-technology/37085/B+L launches a new scleral lenses technology in the US; New World Medical introduces a transparent tip on its Streamline Surgical System, and an OCT platform is cleared in Europe. Learn more about your ad choices. Visit megaphone.fm/adchoicesB+L Receives Approval in Europe for LuxLife IOL
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-receives-approval-in-europe-for-luxlife-iol/37084/Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit meg